Prenatal diagnosis of rearrangements in the fetal 22q11.2 region.,Molecular Cytogenetics

当前位置： X-MOL 学术 › Mol. Cytogenet. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Prenatal diagnosis of rearrangements in the fetal 22q11.2 region.
Molecular Cytogenetics ( IF 1.3 ) Pub Date : 2020-07-08 , DOI: 10.1186/s13039-020-00498-y
Suping Li ₁ , Yuxia Jin ₁ , Jing Yang ₁ , Li Yang ₁ , Ping Tang ₁ , Chiyan Zhou ₁ , Liping Wu ₁ , Jinhua Dong ₁ , Jie Chen ₁ , Huaxiang Shen ₁

Affiliation

22q11.2 deletion syndrome (22q11.2DS) and 22q11.2 duplication syndrome (22q11.2DupS) are the most common copy number variations in humans. The clinical phenotypes of these two syndromes are variable, and there are no large sample data on the prenatal detection rate for these two syndromes in the Chinese population. We recruited 411 pregnant women who showed either abnormal prenatal ultrasound findings or positive prenatal BoBs™ results or who had given birth to a child with chromosomal abnormalities. SNP-array analysis and interphase FISH analysis identified five fetuses with 22q11.2 copy number variants (CNVs), three of which were 22q11.2 deletion syndrome (22q11.2DS) (3/411) and two of which were 22q11.2 duplication syndrome (22q11.2DupS). In all 5 cases of diagnosed 22q11.2 abnormalities, inheritance could not be identified because the parents did not undergo further testing. Our case reports provide a detection rate of 22q11.2 CNVs for fetuses with prenatal diagnostic indications, and early diagnosis of these two syndromes was essential for prenatal intervention in these cases. SNP-array technology is an effective tool in the prenatal diagnosis of 22q11.2 CNVs. The prenatal diagnosis of these two syndromes is helpful for early intervention, which is of great clinical significance.

更新日期：2020-07-08

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>